In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target. Wang X, Tokheim C, Gu SS, Wang B, et al. Cell 2021;184:5357-5374.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang X, Tokheim C, Gu SS, Wang B, et al. In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target. Cell 2021;184:5357-5374.
PMID: 34582788